t
Dr. Martens plc announced on November 2, 2023, that it applied to the FCA and London Stock Exchange for a block listing of 3,500,000 ordinary shares of GBP 0.01 each. These shares are reserved for issuance under the Company's employee share plans, with admission expected to become effective on November 3, 2023.
| Date | 2 Nov 2023 |
| Time | 07:00:12 |
| Category | Capital structure |
| ID | 0933S |
2 November 2023
Dr. Martens plc (the "Company")
Block Listing application
The Company announces today that application has been made to the FCA and to the London Stock Exchange for admission to (i) the Official List and (ii) to trading on the London Stock Exchange's main market for a block listing of securities in respect of a total of 3,500,000 ordinary shares of GBP 0.01 each (the "Ordinary Shares") in the Company. It is expected that admission will become effective on 3 November 2023.
The Ordinary Shares are being reserved under a block listing and will be issued as and when required under the Company's employee share plans.
When issued the Ordinary Shares will rank pari passu in all respects with the existing Ordinary Shares of the Company.
Enquiries:
Investors and analysts
Bethany Barnes, Director of Investor Relations
Gill Hammond, Communications Director
Paul Rolling, Assistant Company Secretary
About Dr. Martens plc
Dr. Martens is an iconic British brand founded in 1960 in Northamptonshire. Originally produced for workers looking for tough, durable boots, the brand was quickly adopted by diverse youth subcultures and associated musical movements. Dr. Martens have since transcended their working-class roots while still celebrating their proud heritage and, six decades later, "Docs" or "DMs" are worn by people around the world who use them as a symbol of empowerment and their own individual attitude. The Company is a constituent of the FTSE 250 index.